Liquid Biopsy Market To See Record Break Revenue $6.80 billion by 2030 at 20.9% CAGR

Liquid Biopsy Market by Product & Service (Kits & Reagents, Platforms & Instruments, and Services), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], and Other Biomarkers), Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancers), and End User (Hospitals & Laboratories and Government & Academic Research Centers): Global Opportunity Analysis and Industry Forecast, 2021-2028.

The global Liquid Biopsy Market garnered $1.20 billion in 2020, and is estimated to reach $6.80 billion by 2028, witnessing a CAGR of 20.9% from 2021 to 2028.

How Big is Liquid Biopsy Market?

Asia-Pacific has the most noteworthy development rate in the market which is developing this is credited because of Asia-Pacific have a huge patient pool with an ascent in discretionary cashflow, expansion in government drives to modernize medical services framework, and ascend in medical services expenditureAn expansion in the quantity of persistent illnesses that lead to organ disappointments is supposed to help the interest for defrosted blood.

Download Free Sample Report Now: 

https://www.alliedmarketresearch.com/request-sample/1891

Covid-19 Scenario:

  • The market has suspended early diagnosis programs owing to the lockdown imposed by government bodies. In addition, there has been a decrease in screenings, visits, therapies, and surgeries related to cancer.
  • The pandemic has also affected the logistics and supplies of cancer diagnostic raw materials and components and other essential commodities required for the production of liquid biopsy.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:

https://www.alliedmarketresearch.com/connect-to-analyst/1891

Based on region, North America contributed to the largest market share in 2019, holding more than two-fifths of the total share, and is expected to maintain its dominant share in terms of revenue by 2028. However, Asia-Pacific is estimated to portray the highest CAGR of 22.7% during the forecast period. Other provinces covered in the report include LAMEA and Europe.

Some of the Top Players in the Global Market Are:

  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • MDxHealth SA
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc
  • Biocept Inc.
  • Guardant Health Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd. (FOUNDATION MEDICINE, INC.)
  • Thermo Fisher Scientific Inc.

Inquire More About the Top Market Players Here:

https://www.alliedmarketresearch.com/purchase-enquiry/1891

Important Questions Being Answered by the Market Report

  • What is the liquid biopsy market size and growth?
  • What are the prominent and latest trends impacting the market?
  • Which regions will observe growth on new occasions?
  • Which players are adopting a functioning and planned framework to obtain customer loyalty?

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Leave a comment

Your email address will not be published. Required fields are marked *